Die Literatur

Produktunabhängige Informationen

  1. Ammon, HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006 Oct;72(12):1100-16.
  2. Werz, O.; Poeckel, D. Boswellic acids: biological actions and molecular targets (Invited Review). Current Med Chem. 2006, 28, 3359-3369
  3. Banno, N.; Akihisa, T.; Yasukawa, K.; Tokuda, H.; Tabata, K.; Nakamura, Y.; Nishimura, R.; Kimura, Y.; Suzuki, T. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol. 2006 Sep 19;107(2):249-53. Epub 2006 Mar 17.
  4. Ammon, H. P. [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases]. Wien Med Wochenschr. 2002;152(15-16):373-8.
  5. Takada, Y.; Ichikawa, H.; Badmaev, V.; Aggarwal, BB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006 Mar 1;176(5):3127-40
  6. Kimmatkar, N.; Thawani, V.; Hingorani, L.; Khiyani, R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomedicine. 2003 Jan;10(1):3-7.
  7. Sander, O.; Herborn, G.; Rau, R. [Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study]. Z Rheumatol. 1998 Feb;57(1):11-6.
  8. Duwiejua, M.; Zeitlin, IJ.; Waterman, PG.; Chapman, J.; Mhango, GJ.; Provan, GJ. Anti-inflammatory activity of resins from some species of the plant family Burseraceae. Planta Med. 1993 Feb;59(1):12-6.
  9. Singh, GB.; Atal, CK. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions. 1986 Jun;18(3-4):407-12.
  10. Chrubasik, JE.; Roufogalis, BD.; Chrubasik, S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res. 2007 Jul;21(7):675-83.
  11. Anthoni, C.; Laukoetter, MG.; Rijcken, E.; Vowinkel, T.; Mennigen, R.; Müller, S.; Senninger, N.; Russell, J.; Jauch, J.; Bergmann, J.; Granger, DN.; Krieglstein, CF. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1131-7. Epub 2006 Jan
  12. Chevrier, MR.; Ryan, AE.; Lee, DY.; Zhongze, M.; Wu-Yan, Z.; Via, CS. Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol. 2005 May;12(5):575-80.
  13. Reichling, J.; Schmökel, H.; Fitzi, J.; Bucher, S.; Saller, R. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweiz Arch Tierheilkd. 2004 Feb;146(2):71-9.
  14. Gupta, I.; Gupta, V.; Parihar, A.; Gupta, S.; Lüdtke, R.; Safayhi, H.; Ammon, HP. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998 Nov 17;3(11):511-4
  15. Mee, JB.; Johnson, CM.; Morar, N.; Burslem, F.; Groves, RW. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol. 2007 Jul;171(1):32-42.
  16. Yoo, H.; Kim, SJ.; Kim, Y.; Lee, H.; Kim, TY. Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol. 2007;39(6):1248-59. Epub 2007 Apr 20.
  17. Huang, MT.; Badmaev, V.;Ding, Y.; Liu, Y.; Xie, JG.; Ho, CT. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors. 2000;13(1-4):225-30.
  18. Altmann, A.; Fischer, L.; Schubert-Zsilavecs, M.; Steinhilber, D.; Werz, O. Boswellic acids activate p42MAPK and p38 MAPK and stimulate the mobilisation of calcium. Biochem Biophys Res Commun. 2002, 190, 185-190.
  19. Altmann, A.; Poeckel, D.; Fischer, L.; Schubert-Zsilavecs, M.; Steinhilber, D.; Werz, O. Coupling of boswellic acid-induced Ca2+-mobilization and MAPK activation to lipid metabolism and peroxide formation in human leukocytes. Br J Pharmacol. 2004, 141, 223-232
  20. Poeckel, D.; Tausch, L.; Altmann, A.; Feißt, C.; Klinkhardt, U.; Graff, J.; Harder, S.; Werz, O. Induction of central signaling pathways and select functional effects in human platelets by ß-boswellic acid. Br. J. Pharmacol. 2005, 146, 514-524.
  21. Poeckel, D.; Tausch, L.; Kather, L.; Jauch, J.; Werz, O. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase, Mol Pharmacol. 2006, 70, 1071-1078